Switch to
More onapp

Sun Pharma Advanced Research Co Ltd

SPARC
Health CarePharmaceuticals
SmallcapWith a market cap of ₹7,185 cr, stock is ranked 417
Moderate RiskStock is 2.64x as volatile as Nifty
193.550.55 (+0.28%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Investment Checklist
BasicPro
Go pro! Unlock deeper insights
Health CarePharmaceuticals
SmallcapWith a market cap of ₹7,185 cr, stock is ranked 417
Moderate RiskStock is 2.64x as volatile as Nifty

Key MetricsEdit

PE RatioPE Ratio
-35.33
PB RatioPB Ratio
230.09
Dividend YieldDiv. Yield
Sector PESector PE
33.90
Sector PBSector PB
4.15
Sector Div YldSctr Div Yld
0.93%

Forecast & RatingsDetailed Forecast 

100%

Analysts have suggested that investors can buy this stock

Price

Price Upside

Pro Only

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Sun Pharma Advanced Research Company Limited is engaged in the research and experimental development on natural sciences and engineering (Pharmacy).

Investor PresentationView older 

Oct 28, 2022

PDF
View Older Presentations

Financial TrendFinancial statements 

2019202020212022196.3886.57258.37144.09-145.42-312.41-151.14-203.40
Revenue
Profit
Loss
All values in ₹ cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent EventsAll events 

Loss of Share Certificates 
Announced OnJan 27, 2023

Sun Pharma Advanced Research Company Limited has informed the Exchange about Loss of Share Certificates | Download

Sun Pharma Advanced Research Company Limited has informed the Exchange about Loss of Share Certificates | Download

Updates 
Announced OnJan 25, 2023

Sun Pharma Advanced Research Company Limited has informed the Exchange regarding 'Launch of SEZABY (Phenobarbital sodium powder for injection) in the U.S. for the treatment of neonatal seizures.'. | Download

Sun Pharma Advanced Research Company Limited has informed the Exchange regarding 'Launch of SEZABY (Phenobarbital sodium powder for injection) in the U.S. for the treatment of neonatal seizures.'. | Download

Loss of Share Certificates 
Announced OnJan 20, 2023

Sun Pharma Advanced Research Company Limited has informed the Exchange about Loss of Share Certificates | Download

Sun Pharma Advanced Research Company Limited has informed the Exchange about Loss of Share Certificates | Download

See all events